Article

Risk counseling important for cataract candidates with history of optic neuropathy

An optic neuropathy resembling nonarteritic ischemic optic neuropathy (NAION) may occur after apparently uncomplicated cataract extraction at a rate higher than would be expected in the general population, said Neil R. Miller, MD. Dr. Miller is professor?ophthalmology, neurology, and neurosurgery, and Frank B. Walsh Professor of Neuro-Ophthalmology, The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore.

An optic neuropathy resembling nonarteritic ischemic optic neuropathy (NAION) may occur after apparently uncomplicated cataract extraction at a rate higher than would be expected in the general population, said Neil R. Miller, MD. Dr. Miller is professor-ophthalmology, neurology, and neurosurgery, and Frank B. Walsh Professor of Neuro-Ophthalmology, The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore.

The rate of optic neuropathy in the first 6 months after cataract extraction is estimated to be about 52 per 100,000 cases. According to results of the Ischemic Optic Neuropathy Decompression Trial, patients with unilateral NAION have about a 15% to 20% 5-year risk of the same event in a fellow eye. Cataract extraction increases this risk two to eight times, Dr. Miller said.

It is thought two types of NAION can occur post-cataract extraction: an immediate event that may be associated with elevated intraoperative IOP and a delayed type that may be more related to the same risk factors as NAION.

Judicious control of IOP during surgery may reduce the risk of the immediate type of post-cataract extraction optic neuropathy. However, there appears to be no way to prevent the delayed event.

"We need to talk to our patients," Dr. Miller urged. "Patients who developed an optic neuropathy after first eye cataract surgery should be told there is an increased risk of this event if cataract extraction is performed in the fellow eye. Those patients with spontaneous NAION in one eye should also be told they have an increased risk following cataract extraction in the fellow eye."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
© 2025 MJH Life Sciences

All rights reserved.